Your Complete Guide to Wegovy vs Mounjaro Comparison
Complete Wegovy vs Mounjaro vs Ozempic Dose Range Availability
Understanding your options between Wegovy, Mounjaro, and the role of Ozempic requires knowing that EverydayMeds stocks every single dose across the complete escalation journey. For Wegovy, we maintain 0.25mg starter doses through to 2.4mg maintenance, whilst our Mounjaro range spans 2.5mg initiation to 15mg maximum doses. This comprehensive availability means patients never face treatment interruption due to dose unavailability - a critical factor when these prescription-only medicines require precise weekly escalation schedules. Your treatment continuity remains uncompromised whether your prescriber recommends Wegovy's five-dose pathway or Mounjaro's six-dose escalation protocol.
The distinction between these treatments extends beyond simple availability. Wegovy contains semaglutide and targets GLP-1 receptors exclusively, whilst Mounjaro utilises tirzepatide to activate both GIP and GLP-1 receptors simultaneously. Ozempic, though containing the same semaglutide as Wegovy, carries diabetes-specific licensing and cannot be legally promoted for weight management in the UK. EverydayMeds ensures you access the appropriately licensed treatment for weight management, with both Wegovy and Mounjaro available through our comprehensive clinical assessment process.
Wegovy vs Mounjaro Pricing Structure and Value Comparison
Wegovy pricing at EverydayMeds reflects the escalation journey, starting with 0.25mg at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to maintenance 2.4mg at £209.99. Mounjaro follows a different pricing structure aligned with its unique dosing protocol. Both treatments benefit from our discount codes - FIRST40 for new customers and DOSE25 for returning patients - applied at checkout to reach these final prices. Bundle options provide convenience for multi-month supplies, with our Ultimate Stability Trio offering three months of Wegovy 2.4mg maintenance for £649.99.
Value comparison between Wegovy and Mounjaro extends beyond unit costs to include practical considerations like storage requirements and injection frequency. Both require once-weekly administration, but Wegovy's superior room temperature stability (6 weeks vs Mounjaro's 21 days) may influence total cost of ownership for frequent travellers. Your prescriber will consider both clinical suitability and practical factors when determining which prescription-only medicine best supports your weight management goals alongside a reduced-calorie diet and increased physical activity.
Clinical Evidence Comparison: Wegovy vs Mounjaro vs Ozempic Trials
Wegovy's clinical foundation rests on the comprehensive STEP trial programme, with STEP 1 demonstrating approximately 15% average weight loss at 68 weeks when used alongside diet and exercise modifications. The recent SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events, expanding Wegovy's clinical utility beyond weight management alone. These findings, published by Wilding et al. in NEJM 2021, established semaglutide's efficacy profile for weight management applications distinct from its diabetes-licensed Ozempic formulation.
Mounjaro's clinical evidence derives from the SURMOUNT programme, evaluating tirzepatide's dual agonist approach across diverse patient populations. Both Wegovy and Mounjaro trials employed different methodologies, patient populations, and endpoints, making direct comparison of percentage weight loss inappropriate. Your prescriber will evaluate individual clinical evidence relevant to your specific health profile rather than comparing trial outcomes across different study designs.
Mechanism Differences: How Wegovy, Mounjaro, and Ozempic Work
Wegovy operates as a selective GLP-1 receptor agonist, mimicking the natural incretin hormone that signals satiety to brain appetite centres. This mechanism reduces appetite, promotes feeling of fullness after smaller meals, and may diminish food cravings by modulating neural pathways controlling eating behaviour. Mounjaro employs a dual agonist approach, simultaneously activating both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors for potentially enhanced metabolic effects. Ozempic shares Wegovy's semaglutide mechanism but carries diabetes-specific licensing, limiting its legal promotion to glycemic control rather than weight management. The choice between Wegovy's targeted approach and Mounjaro's dual pathway depends on your prescriber's clinical assessment of which mechanism suits your metabolic profile.
Streamlined Ordering Process for Wegovy or Mounjaro Comparison
Accessing either Wegovy or Mounjaro through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to capture relevant medical history, current medications, and weight management goals. Following assessment submission, our prescribers conduct thorough evaluation within 3 working days (24-hour express option available) to determine treatment suitability and appropriate starting doses. Once approved, your prescription-only medicine ships via next-day delivery using cold-chain temperature-controlled logistics to maintain product integrity. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance throughout the prescribing and dispensing process. This streamlined pathway eliminates traditional pharmacy visits whilst maintaining clinical safety standards essential for prescription-only weight management treatments.
Storage and Practical Considerations: Wegovy vs Mounjaro vs Ozempic
Storage requirements differ significantly between Wegovy and Mounjaro, potentially influencing treatment choice for active lifestyles. Wegovy maintains stability for 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both require initial refrigeration at 2-8°C until first use, utilising pre-filled FlexTouch (Wegovy) or auto-injector (Mounjaro) delivery systems for convenient weekly administration. Dose escalation protocols are mandatory for both treatments - Wegovy progresses through five distinct doses over 16 weeks to reach 2.4mg maintenance, whilst Mounjaro follows its own escalation schedule. Neither Wegovy nor Mounjaro allows dose-skipping, making reliable pharmacy supply crucial for uninterrupted treatment progression throughout your weight management journey.
Complete Treatment Journey Support: Wegovy and Mounjaro Full Dose Ranges
EverydayMeds' commitment to stocking complete dose ranges for both Wegovy and Mounjaro addresses the critical continuity challenge facing weight management patients. Many pharmacies maintain partial inventory, forcing patients to source different doses from multiple suppliers with potential treatment interruptions. Our comprehensive stock holding means seamless progression from initiation through maintenance phases, regardless of whether your prescriber selects Wegovy's five-dose pathway or Mounjaro's alternative escalation schedule.
This complete availability extends to bundle configurations supporting different patient needs - gentle escalation bundles for side-effect-sensitive patients, rapid progression options for those tolerating higher doses quickly, and maintenance bundles for long-term stability. Both Wegovy and Mounjaro are available from EverydayMeds, allowing your prescriber to help determine which treatment aligns with your clinical requirements and lifestyle preferences without pharmacy availability constraints limiting therapeutic choice.
Start Your Weight Management Comparison Today
Whether clinical assessment leads to Wegovy, Mounjaro, or continued discussion about treatment options, EverydayMeds provides the infrastructure supporting your complete weight management journey. New customers apply code FIRST40 at checkout, whilst returning patients use DOSE25 for continued savings across our comprehensive dose ranges. Our clinical team remains available for guidance throughout treatment, whilst your prescriber maintains oversight of therapeutic decisions. Begin your clinical assessment today at https://everydaymeds.co.uk/collections/wegovy to access expert comparison of these prescription-only medicines alongside professional medical guidance. Remember that both treatments require commitment to reduced-calorie diet and increased physical activity for optimal outcomes, supported by our comprehensive pharmacy services throughout your weight management journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
